Findings from a new study indicate that compared with children who were not exposed to the drug, children with in utero exposure to sodium valproate have lower scores on national tests at age 7 years.
This Week on NeurologyLive® — March 25, 2024
Episode 107: Revealing Mechanisms of Sudden Unexplained Death in Toddlers
NeurologyLive® Friday 5 — March 22, 2024
Episode 105: Recapping Conversations in Neurology From 2023
Unlocking New Treatment Insights for Children With Epileptic Spasms: The TOPAMAD Trial
#PreAANChat: NeurologyLive to Host Pre-AAN 2024 Social Chat